<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">actabiomedica</journal-id><journal-title-group><journal-title xml:lang="ru">Acta Biomedica Scientifica</journal-title><trans-title-group xml:lang="en"><trans-title>Acta Biomedica Scientifica</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2541-9420</issn><issn pub-type="epub">2587-9596</issn><publisher><publisher-name>Scientific Centre for Family Health and Human Reproduction Problems</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29413/ABS.2025-10.1.15</article-id><article-id custom-type="elpub" pub-id-type="custom">actabiomedica-5225</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МОРФОЛОГИЯ, ФИЗИОЛОГИЯ И ПАТОФИЗИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MORPHOLOGY, PHYSIOLOGY AND PATHOPHYSIOLOGY</subject></subj-group></article-categories><title-group><article-title>Значение маркеров остеолизиса и  остеогенеза в  патогенезе кефалогематом у  новорождённых</article-title><trans-title-group xml:lang="en"><trans-title>The importance of markers of osteolysis and osteogenesis in the pathogenesis of cephalohematoma in newborns</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-8050-0159</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сущенко</surname><given-names>Р. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sushchenko</surname><given-names>R. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сущенко Руслан Алексеевич – ассистент кафедры госпитальной хирургии с курсом детской хирургии, </p><p>672000, г. Чита, ул. Горького, 39а</p></bio><bio xml:lang="en"><p>Ruslan A. Sushchenko – Teaching Assistant at the Department of Advanced Level Surgery with a Course of Pediatric Surgery, </p><p>Gorkogo str. 39A, Chita 672000</p></bio><email xlink:type="simple">ruslansushko@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2313-3941</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панченко</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Panchenko</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Панченко Александра Сергеевна – доктор медицинских наук, профессор кафедры неонатологии с  курсами неврологии и  акушерства-гинекологии факультета послевузовского и  дополнительного профессионального образования, </p><p>194100, г. Санкт-Петербург, ул. Литовская, 2</p></bio><bio xml:lang="en"><p>Aleksandra S. Panchenko – Dr. Sc. (Med.), Professor at the Department of Neonatology with Courses of Neurology and Obstetrics and Gynecology of the Faculty of Postgraduate and Additional Professional Education, </p><p>Litovskaya str. 2, Saint Petersburg 194100</p></bio><email xlink:type="simple">sashawomen18@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Читинская государственная медицинская академия» Минздрава России</institution></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Санкт-Петербургский государственный педиатрический медицинский университет» Минздрава России</institution></aff><aff xml:lang="en"><institution>St. Petersburg State Pediatric Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>03</month><year>2025</year></pub-date><volume>10</volume><issue>1</issue><fpage>144</fpage><lpage>150</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сущенко Р.А., Панченко А.С., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Сущенко Р.А., Панченко А.С.</copyright-holder><copyright-holder xml:lang="en">Sushchenko R.A., Panchenko A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.actabiomedica.ru/jour/article/view/5225">https://www.actabiomedica.ru/jour/article/view/5225</self-uri><abstract><sec><title>Обоснование</title><p>Обоснование. Особое значение в процессе репарации при кефалогематомах имеет патологическое ремоделирование костей свода черепа. Проследить изменения состояния костной ткани при кефалогематомах можно, основываясь на определении концентрации маркеров остеолизиса и остеогенеза в крови у новорождённых.</p></sec><sec><title>Цель работы</title><p>Цель работы. Определить уровень маркеров остеолизиса (бета-CrossLaps) и остеогенеза (N-остеокальцин, рецептор фактора роста эндотелия сосудов 1-го типа (VEGFR1, vascular endothelial growth factor receptor 1)) в сыворотке венозной крови у новорождённых с кефалогематомами; оценить динамику локальных костных изменений.</p></sec><sec><title>Методы</title><p>Методы. Под наблюдением находилось 90 новорождённых: 30 пациентов с  кефалогематомами средних и  больших размеров (выполняли пункцию кефалогематомы); 30  пациентов с  кефалогематомами малых размеров (пункцию не выполняли); 30 здоровых детей. Уровень маркеров остеолизиса и остеогенеза в крови определяли методом фотометрии с использованием иммуноферментного анализа. Регистрацию локальных костных изменений осуществляли методами ультрасонографии и краниометрии.</p></sec><sec><title>Результаты</title><p>Результаты. Уровень бета-CrossLaps у пациентов первой группы был выше в 2,57 раза, у пациентов второй группы – в 4,45 раза, чем у здоровых новорождённых, на 10-е сутки (p &lt; 0,001). Концентрация N-остеокальцина на 10-е сутки во второй группе превышала показатели первой группы в 1,43 раза (p&gt; &lt; 0,001). Концентрация N-остеокальцина на 10-е сутки во второй группе превышала показатели первой группы в 1,43 раза (p &lt; 0,001). Концентрация VEGFR1 у  пациентов первой группы была выше в 1,9 раза, а у пациентов второй группы – в 3,01 раза, чем в группе контроля (p &lt; 0,001). Локальные остеолитические изменения черепа преобладали у  пациентов первой группы на  10-е  сутки, а  оссификация – во  второй на 28-е сутки наблюдения (p &lt; 0,001).</p></sec><sec><title>Заключение</title><p>Заключение. Репарация при  кефалогематомах сопряжена с  явлениями резорбции костей свода черепа и патологической оссификацией кровоизлияния в зоне сепарации надкостницы. Изменение уровня маркеров остеогенеза и остеолизиса в сыворотке венозной крови у пациентов с кефалогематомами может отражать динамику и направленность патофизиологического процесса ремоделирования костей свода черепа.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Of particular importance in the repair process for cephalohematomas is the pathological remodeling of the bones of the cranial vault. Local changes in the bones of the skull are accompanied by the processes of osteolysis and osteogenesis and have uncertain dynamics. Changes in the state of bone tissue in cephalohematomas can be monitored based on determining the concentration of markers of osteolysis and osteogenesis in the blood of newborns.</p></sec><sec><title>The  aim</title><p>The  aim. To  define the  level of  markers of  osteolysis (beta-CrossLaps) and osteogenesis (N-osteocalcin, vascular endothelial growth factor receptor 1 (VEGFR1)) in  the  venous blood serum of  newborns with cephalohematomas and evaluate the dynamics of local bone changes.</p></sec><sec><title>Methods</title><p>Methods. There were 90 newborns under observation, 30 patients with medium and large cephalohematomas (the cephalohematoma was punctured), 30 patients with small cephalohematomas (the puncture was not performed) and 30 healthy children. The level of markers of osteolysis and osteogenesis in the blood was determined by photometry using an enzyme-linked immunosorbent assay. Registration of local bone changes was carried out using ultrasonography and craniometry.</p></sec><sec><title>Results</title><p>Results. The level of beta-CrossLaps in patients from the first group was 2.57 times higher, and in patients from the second group 4.45 times higher, than in healthy newborns on day 10 (p &lt; 0.001). The concentration of N-Osteocalcin on day 10 in the second group was 1.43 times higher than in the first group (p &lt; 0.001). The concentration of VEGFR1 in patients from the first group was 1.9 times higher, and in patients from the second group 3.01 times higher than in the control group (p &lt; 0.001). Local osteolytic changes in the skull predominated in patients of the first group on day 10, and ossification in the second group on day 28 of observation (p &lt; 0.001).</p></sec><sec><title>Conclusion</title><p>Conclusion. Reparation for cephalohematomas is associated with the phenomena of  resorption of  the  bones of  the  cranial vault and pathological ossification of hemorrhage in the zone of periosteum separation. Changes in the level of markers of osteogenesis and osteolysis in venous blood serum in patients with cephalohematomas may reflect the dynamics and direction of the pathophysiological process of remodeling of the bones of the cranial vault.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>кефалогематома</kwd><kwd>новорождённый</kwd><kwd>оссификация</kwd><kwd>остеолизис</kwd><kwd>бета-CrossLaps</kwd><kwd>N-остеокальцин</kwd><kwd>VEGFR1</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cephalohematoma</kwd><kwd>newborn</kwd><kwd>ossification</kwd><kwd>osteolysis</kwd><kwd>Beta-CrossLaps</kwd><kwd>N-Osteocalcin</kwd><kwd>VEGFR1</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Иова А.С. Особенности ведения новорождённых с кефалогематомами: индивидуализированный подход и минимальная инвазивность. StatusPraesens. Педиатрия и неонатология. 2020; 3-4(70-72): 101-105.</mixed-citation><mixed-citation xml:lang="en">Iova AS. Features of the management of newborns with cephalohematomas: Individualized approach and minimal invasiveness. StatusPraesens. Pediatrics and Neonatology. 2020; 3-4(70-72): 101-105. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Киосов А.Ф., Галиаскарова А.Р. Факторы риска и клинические особенности формирования кефалогематом у новорожденных детей. Уральский медицинский журнал. 2019; 15(183): 23-27. doi: 10.25694/urmj.2019.15.07</mixed-citation><mixed-citation xml:lang="en">Kiosov AF, Galiaskarova AR. Risk factors and clinical features of the formation of cephalhematoma in newborns. Ural Medical Journal. 2019; 15(183): 23-27. (In  Russ.). doi:  10.25694/urmj.2019.15.07</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kandemirli SG, Cingoz M, Bilgin C, Olmaz B. Temporal evolution of imaging findings in ossified cephalohematoma. J Craniofac Surg. 2020; 31(4): 375-378. doi: 10.1097/scs.0000000000006319</mixed-citation><mixed-citation xml:lang="en">Kandemirli SG, Cingoz M, Bilgin C, Olmaz B. Temporal evolution of imaging findings in ossified cephalohematoma. J Craniofac Surg. 2020; 31(4): 375-378. doi: 10.1097/scs.0000000000006319</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Calloni T, Trezza A, Mazzoleni F, Cavaliere M, Canonico F, Sganzerla E, et al. Infant ossified cephalohematoma: A review of the surgical management and technical update. J Neurosurg Sci. 2020; 64(6): 552-557. doi: 10.23736/s0390-5616.20.05052-3</mixed-citation><mixed-citation xml:lang="en">Calloni T, Trezza A, Mazzoleni F, Cavaliere M, Canonico F, Sganzerla  E, et  al. Infant ossified cephalohematoma: A  review of the surgical management and technical update. J Neurosurg Sci. 2020; 64(6): 552-557. doi: 10.23736/s0390-5616.20.05052-3</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Üçer M, Taçyıldız AE, Aydın I, Akkoyun KN, Işık S. Observational case analysis of neonates with large cephalohematoma. Cureus. 2021; 13(4): 14415. doi: 10.7759/cureus.14415</mixed-citation><mixed-citation xml:lang="en">Üçer M, Taçyıldız AE, Aydın I, Akkoyun KN, Işık S. Observational case analysis of neonates with large cephalohematoma. Cureus. 2021; 13(4): 14415. doi: 10.7759/cureus.14415</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kopacz A, Nagy L, Demke J. Bilateral cephalohematoma with sagittal synostosis and scaphocephaly. J Craniofac Surg. 2020; 31(3): 260-261. doi: 10.1097/scs.0000000000006223</mixed-citation><mixed-citation xml:lang="en">Kopacz A, Nagy L, Demke J. Bilateral cephalohematoma with sagittal synostosis and scaphocephaly. J Craniofac Surg. 2020; 31(3): 260-261. doi: 10.1097/scs.0000000000006223</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Wong CH, Foo CL, Seow WT. Calcified cephalohematoma: Classification, indications for surgery and techniques. J Craniofac Surg. 2006; 17(5): 970-979. doi: 10.1097/01.scs.0000229552.82081.de</mixed-citation><mixed-citation xml:lang="en">Wong CH, Foo CL, Seow WT. Calcified cephalohematoma: Classification, indications for surgery and techniques. J Craniofac Surg. 2006; 17(5): 970-979. doi: 10.1097/01.scs.0000229552.82081.de</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ulma RM, Sacks G, Rodoni BM, Duncan A, Buchman AT, Buchman BC, et al. Management of calcified cephalohematoma of infancy: The University of Michigan 25-year experience. Plast Reconstr Surg. 2021; 148(2): 409-417. doi: 10.1097/prs.0000000000008199</mixed-citation><mixed-citation xml:lang="en">Ulma RM, Sacks G, Rodoni BM, Duncan A, Buchman AT, Buchman BC, et al. Management of calcified cephalohematoma of infancy: The University of Michigan 25-year experience. Plast Reconstr Surg. 2021; 148(2): 409-417. doi: 10.1097/prs.0000000000008199</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Мирсадыков Д.А., Миножов М.М., Абдумажитова А.М., Махмаев Т.Й. Вариант эволюции кальцифицированной кефалогематомы. Нейрохирургия и неврология детского возраста. 2010; 2(24): 50-57.</mixed-citation><mixed-citation xml:lang="en">Mirsadykov DA, Minozhov MM, Abdumazhitova AM, Makhmaev TI. Variants of evolution calcificated cephalohematoma. Pediatric Neurosurgery and  Neurology. 2010; 2(24): 50-57. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Васильева Е.А., Строкова Т.В., Сурков А.Г. Ремоделирование костной ткани у детей с печеночными формами гликогеновой болезни. Русский медицинский журнал. 2019; 27(7): 34-38.</mixed-citation><mixed-citation xml:lang="en">Vasilyeva EA, Strokova TV, Surkov AG. Bone remodeling in children with hepatic forms of glycogen storage disease. Russian Medical Journal. 2019; 27(7): 34-38. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Халяпина А.Б., Паршиков М.В., Ярыгин Н.В. Ранняя диагностика костно-хрящевых изменений при остеоартрите. Кафедра травматологии и ортопедии. 2022; 3(49): 90-98. doi: 10.17238/2226-2016-2022-3-90-98</mixed-citation><mixed-citation xml:lang="en">Khalyapina AB, Parshikov MV, Yarygin NV. Early diagnosis of osteocartilaginous changes in osteoarthritis. Department of Traumatology &amp; Orthopedics. 2022; 3(49): 90-98. (In Russ.). doi: 10.17238/2226-2016-2022-3-90-98</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Зейналов Ю.Л., Дьячкова Г.В., Сутягин И.В., Ларионова Т.А., Дьячков К.А. Показатели кальциевого обмена и маркеры костеобразования у больных идиопатическим сколиозом в зависимости от возраста. Забайкальский медицинский вестник. 2021; 2: 47-55. doi: 10.52485/19986173_2021_2_47</mixed-citation><mixed-citation xml:lang="en">Zejnalov JL, Diachkova GV, Sutyagin IV, Larionova TA, Diachkov KA. Indicators of calcium metabolism and markers of bone formation in patients with idiopathic scoliosis depending on age. Transbaikalian Medical Bulletin. 2021; 2: 47-55. (In Russ.). doi: 10.52485/19986173_2021_2_47</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Рудько А.С., Эфендиева М.Х., Будзинская М.В., Карпилова М.А. Влияние фактора роста эндотелия сосудов на ангиогенез и нейрогенез. Вестник офтальмологии. 2017; 133(3): 75-81. doi: 10.17116/oftalma2017133375-80</mixed-citation><mixed-citation xml:lang="en">Rud’ko AS, Efendieva MKh, Budzinskaia MV, Karpilova MA. Influence of vascular endothelial growth factor on angiogenesis and neurogenesis. Russian Annals ofOphthalmology. 2017; 133(3): 75-81. (In Russ.). doi: 10.17116/oftalma2017133375-80</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Бозо И.Я., Рожков С.И., Комлев В.С., Воложин Г.А., Еремин И.И., Смирнов И.В., и др. Сравнительная оценка биологической активности ген-активированных остеопластических материалов из октакальциевого фосфата и плазмидных ДНК, несущих гены VEGF и SDF: часть 2 – in vivo. Гены и клетки. 2017; 12(4): 39-46. doi: 10.23868/201707028</mixed-citation><mixed-citation xml:lang="en">Bozo IY, Rozhkov SI, Komlev VS, Volozhin GA, Eremin  II, Smirnov  IV, et  al. Biological activity comparative evaluation of  the  gene-activated bone substitutes made of  octacalcium phosphate and  plasmid DNA carrying VEGF and SDF genes: Part 2 – in vivo. Genes &amp; Cells. 2017; 12(4): 39-46. (In Russ.). doi: 10.23868/201707028</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров В.А. Алгоритмы статистического анализа данных биомедицинских исследований с помощью пакета программ SPSS (доступным языком): учебное пособие. М.: Логосфера; 2022.</mixed-citation><mixed-citation xml:lang="en">Mudrov VA. Algorithms for statistical analysis of biomedical research data using the SPSS software package (in accessible language): Textbook. Moscow: Logosfera; 2022. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Carvalho F, Medeiros I, Correa F, Pontes FS, Amado M. Hard cranial mass: Cephalohematoma? J Pediatr Neonat Individual Med. 2019; 8(1): 080107. doi: 10.7363/080107</mixed-citation><mixed-citation xml:lang="en">Carvalho F, Medeiros I, Correa F, Pontes FS, Amado M. Hard cranial mass: Cephalohematoma? J Pediatr Neonat Individual Med. 2019; 8(1): 080107. doi: 10.7363/080107</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Idrissi KJ, Mimi AL, Hassani YE, Haloua M, Alami B, Lamrani AY, et al. Calcified cephalohematoma 02 cases report. IOSR J Dent Med Sci. 2019; 18(1): 61-65. doi: 10.9790/0853-1801036165</mixed-citation><mixed-citation xml:lang="en">Idrissi KJ, Mimi AL, Hassani YE, Haloua M, Alami B, Lamrani AY, et al. Calcified cephalohematoma 02 cases report. IOSR J Dent Med Sci. 2019; 18(1): 61-65. doi: 10.9790/0853-1801036165</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Vigo V, Battaglia DI, Frassanito P, Tamburrini G, Caldarelli M, Massimi L. Calcified cephalohematoma as an unusual cause of EEG anomalies: Case report. J Neurosurg Pediatr. 2017; 19(1): 46-50. doi: 10.3171/2016.6.peds16120</mixed-citation><mixed-citation xml:lang="en">Vigo V, Battaglia DI, Frassanito P, Tamburrini G, Caldarelli M, Massimi L. Calcified cephalohematoma as an unusual cause of EEG anomalies: Case report. J Neurosurg Pediatr. 2017; 19(1): 46-50. doi: 10.3171/2016.6.peds16120</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Komori T. Functions of osteocalcin in bone, pancreas, testis, and muscle. Int J Mol Sci. 2020; 21(20): 7513. doi: 10.3390/ijms21207513</mixed-citation><mixed-citation xml:lang="en">Komori T. Functions of  osteocalcin in  bone, pancreas, testis, and muscle. Int J Mol Sci. 2020; 21(20): 7513. doi: 10.3390/ijms21207513</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wang JS, Mazur CM, Wein MN. Sclerostin and osteocalcin: Candidate bone-produced hormones. Front Endocrinol (Lausanne). 2021; 12: 584147. doi: 10.3389/fendo.2021.584147</mixed-citation><mixed-citation xml:lang="en">Wang JS, Mazur CM, Wein MN. Sclerostin and osteocalcin: Candidate bone-produced hormones. Front Endocrinol (Lausanne). 2021; 12: 584147. doi: 10.3389/fendo.2021.584147</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Stock M, Schett G. Vitamin K-dependent proteins in skeletal development and disease. Int J Mol Sci. 2021; 22(17): 9328. doi: 10.3390/ijms22179328</mixed-citation><mixed-citation xml:lang="en">Stock M, Schett G. Vitamin K-dependent proteins in skeletal development and disease. Int J Mol Sci. 2021; 22(17): 9328. doi: 10.3390/ijms22179328</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lombardi G, Perego S, Luzi L, Banfi G. A four-season molecule: Osteocalcin. Updates in its physiological roles. Endocrine. 2015; 48(2): 394-404. doi: 10.1007/s12020-014-0401-0</mixed-citation><mixed-citation xml:lang="en">Lombardi G, Perego S, Luzi L, Banfi G. A four-season molecule: Osteocalcin. Updates in its physiological roles. Endocrine. 2015; 48(2): 394-404. doi: 10.1007/s12020-014-0401-0</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rashdan NA, Sim AM, Cui L, Phadwal K, Roberts FL, Carter R, et al. Osteocalcin regulates arterial calcification via altered Wnt signaling and glucose metabolism. J Bone Miner Res. 2020; 35(2): 357-367. doi: 10.1002/jbmr.3888</mixed-citation><mixed-citation xml:lang="en">Rashdan  NA, Sim  AM, Cui  L, Phadwal  K, Roberts  FL, Carter R, et al. Osteocalcin regulates arterial calcification via altered Wnt signaling and glucose metabolism. J Bone Miner Res. 2020; 35(2): 357-367. doi: 10.1002/jbmr.3888</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Shibuya M. VEGF-VEGFR system as a target for suppressing inflammation and other diseases. Endocr Metab Immune Disord Drug Targets. 2015; 15(2): 135-144. doi: 10.2174/18715303156661 50316121956</mixed-citation><mixed-citation xml:lang="en">Shibuya M. VEGF-VEGFR system as a target for suppressing inflammation and other diseases. Endocr Metab Immune Disord Drug Targets. 2015; 15(2): 135-144. doi: 10.2174/18715303156661 50316121956</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Uemura A, Fruttiger M, D’Amore PA, De Falco S, Joussen AM, Sennlaub F, et al. VEGFR1 signaling in retinal angiogenesis and microinflammation. Prog Retin Eye Res. 2021; 84: 100954 doi: 10.1016/j.preteyeres.2021.100954</mixed-citation><mixed-citation xml:lang="en">Uemura  A, Fruttiger  M, D’Amore  PA, De  Falco  S, Joussen AM, Sennlaub F, et al. VEGFR1 signaling in retinal angiogenesis and  microinflammation. Prog Retin Eye Res. 2021; 84: 100954 doi: 10.1016/j.preteyeres.2021.100954</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
